Practice Advancement & Education

Practice Advancement & Education
Susanne Barnett
Susanne Barnett, Associate Professor (CHS)

Research Interests: Dr. Barnett's scholarship is motivated by identified areas of improvement in the classroom and within her clinical practice site. Her research relies on quality improvement and assurance processes to guide antimicrobial stewardship and teaching practices.

Eric Buxton
Eric Buxton, Clinical Professor and Chair

Professional Interests: Development, implementation and evaluation of continuing education offerings for individuals in the pharmaceutical industry.

Steven Ebert
Steven Ebert, Clinical Professor

Clinical Practice and Research Interests: Antimicrobial resistance, antimicrobial pharmacokinetics/ pharmacodynamics, and appropriate utilization of healthcare resources.

Casey Gallimore
Casey Gallimore, Professor
Barry Gidal
Barry Gidal, Professor (CHS)

Clinical Practice:  Neurology

Research Interests:  Pharmacokinetics, pharmacodynamics, and the metabolic effects of anticonvulsant medications.

Paul Hutson
Paul Hutson, Professor (CHS)

Clinical Practice: Palliative Care; Oncology / Hematology.

Research Interests: Palliative care; Population pharmacokinetic modeling; Entheogens.

Mara Kieser
Mara Kieser, Professor (CHS)

Clinical Practice: Long Term Care. 

Research Interests: Health Outcomes in long term care; Benefits of student clerkships.

Karen Kopacek
Karen Kopacek, Associate Professor (CHS)

Clinical Practice:  Cardiac Rehabilitation; Rural Health (acute care)

Marina Maes
Marina Maes, Associate Professor

Clinical Practice:  Family Medicine/Ambulatory Care Clinic

Research Interests: Scholarship of teaching and learning (SoTL), evaluation of pharmacist services on clinical outcomes, expansion of reproductive health services and education

Amanda Margolis
Amanda Margolis, Associate Professor (CHS)

Research Interests: Preceptor development, interprofessional education in an experiential setting, teaching and learning of evidence-based medicine

Beth Martin
Beth Martin, Professor (CHS) and Chair

Clinical Interests: Community pharmacy practice.  Older adult medicines and reducing falls risk.

Research Interests: Evaluate the effectiveness of educational methodologies to enhance pharmacist, student or patient learning and confidence, and the degree to which performance-based abilities are transferred from the learning environment to the real world setting. 

Michael Pitterle
Michael Pitterle, (None)

Research Interests: Development and evaluation of computer applications in pharmacy student education and practice.

Andrea Porter
Andrea Porter, Professor (CHS)

Clinical Practice:  Anticoagulation

Research Interests:  Educational-based scholarship, particularly educational innovation and teaching methods, as well as clinical research involving anticoagulation

Edward Portillo
Edward Portillo, Associate Professor (CHS)

Clinical Practice: Primary Care/Ambulatory Care Clinic Practice

Research Interests: Evaluation and expansion of interprofessional service models using dissemination science to incorporate pharmacists as patient care providers. Education-based research involving evaluation of thematic curricular pathways to best position students for success post-graduation.

Trisha Seys Ranola
Trisha Seys Ranola, Clinical Assistant Professor

Clinical practice: Interdisciplinary team geriatric medicine; diabetes; cardiac: hypertension, lipids, heart failure; anticoagulation; anemia; polypharmacy reduction

Denise Walbrandt Pigarelli
Denise Walbrandt Pigarelli, Associate Professor (CHS)

Clinical Practice: Diabetes.

Research Interests: Clinical and quality of life outcomes of drug therapy and pharmaceutical care.  Academic research interests include outcomes related to instructional design and assessment

Cody Wenthur
Cody Wenthur, Associate Professor (Drug Action)| Wenthur Lab Website | Wisconsin Opioid Overdose Resource Center (WOORC)

Research Interests:  Synaptic plasticity in substance use and major depressive disorders; Development of antibodies against cannabinoids, opioids, sedative-hypnotics, and classical psychedelics; Immunologic biomarkers of drug use; Implementation of novel psychiatric treatments, including vaccine-based approaches and medication-assisted psychotherapy

^ Back to top